SQZ Biotechnologies Co SQZB:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 05/13/24 EDT
0.021UNCH (UNCH)
52 week range
0.01 - 0.65
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.021
  • 52 Week High0.65
  • 52 Week High Date05/15/23
  • 52 Week Low0.01
  • 52 Week Low Date11/28/23

Key Stats

  • Market Cap619,313.717
  • Shares Out29.49M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change5.53

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.021
  • 52 Week High0.65
  • 52 Week High Date05/15/23
  • 52 Week Low0.01
  • 52 Week Low Date11/28/23
  • Market Cap619,313.717
  • Shares Out29.49M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change5.53

RATIOS/PROFITABILITY

  • EPS (TTM)-2.43
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-0.00
  • EBITDA (TTM)-58.916M
  • ROE (TTM)-203.37%
  • Revenue (TTM)12.121M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-591.07%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SQZ Biotechnologies Co

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
SQZ Biotechnologies Company is a clinical-stage biotechnology company. The Company is focused on unlocking the full potential of cell therapies to benefit patients. In oncology, it is developing cell therapy platforms that are based on directing tumor antigen-specific immune activation via engineered antigen presentation. Its clinical-stage cell therapy candidates include SQZ Enhanced APC (eAPC) Platform, SQZ Activating Antigen Carrier (AAC) Platform and SQZ Tolerizing...
Bernard Coulie M.D., Ph.D.
Independent Non-Executive Chairman of the Board
Howard Bernstein M.D., Ph.D.
Interim Chief Executive Officer, Director
Richard Capasso
Chief Accounting Officer
Lawrence Knopf
General Counsel
Address
200 Arsenal Yards Blvd, Suite 210
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
NTII
Neurobiological Technologies Inc
0.00UNCHUNCH
EIGRQ
Eiger BioPharmaceuticals Inc
2.12-0.13-5.78%
EVFM
Evofem Biosciences Inc
0.0152+0.0022+16.9753%
TCON
TRACON Pharmaceuticals Inc
2.00-0.02-0.99%
EIGRQ
Eiger BioPharmaceuticals Inc
2.12-0.13-5.78%